Author:
Fredriksen Mats,Halmøy Anne,Faraone Stephen V.,Haavik Jan
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference81 articles.
1. Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose–titration, 1-year study;Adler;J. Clin. Psychopharmacol.,2011
2. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial;Adler;J. Clin. Psychopharmacol.,2009
3. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD;Adler;J. Atten. Disord.,2009
4. Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis;Adler;J. Clin. Psychiatry,2005
5. Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study;Adler;J. Atten. Disord.,2008
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献